Cambrex to Announce Third Quarter 2016 Financial Results on November 4, 2016
November 01 2016 - 1:35PM
Cambrex Corporation (NYSE:CBM), a leading manufacturer of small
molecule innovator and generic Active Pharmaceutical Ingredients
(APIs), today announced that third quarter 2016 financial results
will be released on Friday, November 4, 2016 before the market
opens.
The Company will host a conference call to discuss the financial
results.
|
Third Quarter 2016
Earnings Conference Call |
|
|
|
|
When: |
Friday,
November 4, 2016 at 8:30 a.m. Eastern Time |
|
|
Dial-in: |
1-888-262-8770 for
U.S. |
|
|
1-913-312-1227 for International |
|
Passcode:
2914880 |
|
|
|
|
Dial-in
Replay: |
1-888-203-1112 for
U.S. |
|
|
1-719-457-0820 for International |
|
Passcode:
2914880 |
|
|
Available
through Friday, November 11, 2016 |
|
|
Webcast: |
www.cambrex.com |
|
|
|
|
About
CambrexCambrex Corporation is an innovative life
sciences company that provides products, services and technologies
to accelerate the development and commercialization of small
molecule therapeutics. The Company offers Active
Pharmaceutical Ingredients (APIs), advanced intermediates and
enhanced drug delivery products for branded and generic
pharmaceuticals. Development and manufacturing capabilities include
enzymatic biotransformations, high potency APIs, high energy
chemical synthesis and controlled substances. For more
information, please visit www.cambrex.com.
Contact:
Stephanie LaFiura
Investor Relations Associate
Tel: 201-804-3037
Email: stephanie.lafiura@cambrex.com
Cambrex (NYSE:CBM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cambrex (NYSE:CBM)
Historical Stock Chart
From Apr 2023 to Apr 2024